Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1010

1.

Patient Safety in Anesthesia.

Deutsch ES, Straker T.

Otolaryngol Clin North Am. 2019 Sep 17. pii: S0030-6665(19)30134-3. doi: 10.1016/j.otc.2019.08.003. [Epub ahead of print] Review.

PMID:
31540768
2.

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2.

Beinse G, Tellier V, Charvet V, Deutsch E, Borget I, Massard C, Hollebecque A, Verlingue L.

JCO Clin Cancer Inform. 2019 Sep;3:1-10. doi: 10.1200/CCI.19.00023.

PMID:
31539266
3.

[RadioTransNet, the French network for preclinical research in oncological radiotherapy].

Bayart E, Azria D, Balosso J, Benderitter M, Cohen-Jonathan Moyal E, Delpon G, Deutsch E, Dutreix M, Lacornerie T, Romeo PH, Marchesi V, Maingon P.

Cancer Radiother. 2019 Aug 24. pii: S1278-3218(19)30331-2. doi: 10.1016/j.canrad.2019.07.155. [Epub ahead of print] French.

PMID:
31455590
4.

Progress on Identifying and Characterizing the Human Proteome: 2019 Metrics from the HUPO Human Proteome Project.

Omenn GS, Lane L, Overall CM, Corrales FJ, Schwenk JM, Paik YK, Van Eyk JE, Liu S, Pennington S, Snyder MP, Baker MS, Deutsch EW.

J Proteome Res. 2019 Sep 13. doi: 10.1021/acs.jproteome.9b00434. [Epub ahead of print]

PMID:
31430157
5.

[Definitive or neo-adjuvant chemoradiation in esophageal carcinoma?]

Modesto A, Carrère N, Guimbaud R, Rives M, Deutsch É, Quéro L, Créhange G.

Cancer Radiother. 2019 Aug 14. pii: S1278-3218(19)30296-3. doi: 10.1016/j.canrad.2019.06.010. [Epub ahead of print] French.

PMID:
31421997
6.

Evolutionary drivers of group foraging: A new framework for investigating variance in food intake and reproduction.

Grinsted L, Deutsch EK, Jimenez-Tenorio M, Lubin Y.

Evolution. 2019 Aug 17. doi: 10.1111/evo.13826. [Epub ahead of print]

PMID:
31420977
7.

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.

Kumar T, Schernberg A, Busato F, Laurans M, Fumagalli I, Dumas I, Deutsch E, Haie-Meder C, Chargari C.

Cancer Manag Res. 2019 Jul 8;11:6285-6297. doi: 10.2147/CMAR.S195989. eCollection 2019.

8.

Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy.

Deutsch E, Chargari C, Galluzzi L, Kroemer G.

Lancet Oncol. 2019 Aug;20(8):e452-e463. doi: 10.1016/S1470-2045(19)30171-8. Epub 2019 Jul 29. Review.

PMID:
31364597
9.

Brachytherapy: An overview for clinicians.

Chargari C, Deutsch E, Blanchard P, Gouy S, Martelli H, Guérin F, Dumas I, Bossi A, Morice P, Viswanathan AN, Haie-Meder C.

CA Cancer J Clin. 2019 Sep;69(5):386-401. doi: 10.3322/caac.21578. Epub 2019 Jul 30. Review.

10.

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.

Seban RD, Nemer JS, Marabelle A, Yeh R, Deutsch E, Ammari S, Moya-Plana A, Mokrane FZ, Gartrell RD, Finkel G, Barker L, Bigorgne AE, Schwartz LH, Saenger Y, Robert C, Dercle L.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2298-2310. doi: 10.1007/s00259-019-04411-7. Epub 2019 Jul 25.

PMID:
31346755
11.

Fast dose fractionation using ultra-short laser accelerated proton pulses can increase cancer cell mortality, which relies on functional PARP1 protein.

Bayart E, Flacco A, Delmas O, Pommarel L, Levy D, Cavallone M, Megnin-Chanet F, Deutsch E, Malka V.

Sci Rep. 2019 Jul 12;9(1):10132. doi: 10.1038/s41598-019-46512-1.

12.

PTMProphet: Fast and Accurate Mass Modification Localization for the Trans-Proteomic Pipeline.

Shteynberg DD, Deutsch EW, Campbell DS, Hoopmann MR, Kusebauch U, Lee D, Mendoza L, Midha MK, Sun Z, Whetton AD, Moritz RL.

J Proteome Res. 2019 Jul 22. doi: 10.1021/acs.jproteome.9b00205. [Epub ahead of print]

PMID:
31290668
13.

School education to increase organ donation and awareness of issues in transplantation in the UK.

Byrne M, Stainer B, Symington M, Leighton J, Jackson H, Singhal N, Patel S, Shiel-Rankin S, Mayes J, Mogg J, Bonham T, Smit A, Deutsch E, Thompson E, Wilson C.

Pediatr Transplant. 2019 Aug;23(5):e13492. doi: 10.1111/petr.13492. Epub 2019 Jun 3.

PMID:
31157497
14.

Radiomics to predict response to immunotherapy, bridging the gap from proof of concept to clinical applicability?

Deutsch E, Paragios N.

Ann Oncol. 2019 May 24. pii: mdz150. doi: 10.1093/annonc/mdz150. [Epub ahead of print] No abstract available.

PMID:
31124559
15.

Proteomics Standards Initiative Extended FASTA Format.

Binz PA, Shofstahl J, Vizcaíno JA, Barsnes H, Chalkley RJ, Menschaert G, Alpi E, Clauser K, Eng JK, Lane L, Seymour SL, Sánchez LFH, Mayer G, Eisenacher M, Perez-Riverol Y, Kapp EA, Mendoza L, Baker PR, Collins A, Van Den Bossche T, Deutsch EW.

J Proteome Res. 2019 Jun 7;18(6):2686-2692. doi: 10.1021/acs.jproteome.9b00064. Epub 2019 May 23.

16.

Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy.

Seban RD, Robert C, Dercle L, Yeh R, Dunant A, Reuze S, Schernberg A, Sun R, Mignot F, Terroir M, Schlumberger M, Haie-Meder C, Chargari C, Deutsch E.

Oncoimmunology. 2019 Mar 6;8(5):e1574197. doi: 10.1080/2162402X.2019.1574197. eCollection 2019.

17.

Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel.

Clémenson C, Liu W, Bricout D, Soyez-Herkert L, Chargari C, Mondini M, Haddad R, Wang-Zhang X, Benel L, Bloy C, Deutsch E.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1141-1152. doi: 10.1016/j.ijrobp.2019.04.031. Epub 2019 May 4.

PMID:
31063799
18.

Plerixafor for the Treatment of WHIM Syndrome.

Levy A, Mondini M, Deutsch E.

N Engl J Med. 2019 Apr 18;380(16):e25. doi: 10.1056/NEJMc1901646. No abstract available.

PMID:
30995387
19.

Toward Completion of the Human Proteome Parts List: Progress Uncovering Proteins That Are Missing or Have Unknown Function and Developing Analytical Methods.

Paik YK, Overall CM, Corrales F, Deutsch EW, Lane L, Omenn GS.

J Proteome Res. 2018 Dec 7;17(12):4023-4030. doi: 10.1021/acs.jproteome.8b00885. No abstract available.

20.

Reproducible big data science: A case study in continuous FAIRness.

Madduri R, Chard K, D'Arcy M, Jung SC, Rodriguez A, Sulakhe D, Deutsch E, Funk C, Heavner B, Richards M, Shannon P, Glusman G, Price N, Kesselman C, Foster I.

PLoS One. 2019 Apr 11;14(4):e0213013. doi: 10.1371/journal.pone.0213013. eCollection 2019.

21.

Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.

Scholl S, Popovic M, de la Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M, Samuels S, Zijlmans H, Kenter G, Hillemanns P, Dema S, Dema A, Malenkovic G, Djuran B, Floquet A, Garbay D, Guyon F, Colombo PE, Fabbro M, Kerr C, Ngo C, Lecuru F, Campo ERD, Coutant C, Marchal F, Mesgouez-Nebout N, Fourchotte V, Feron JG, Morice P, Deutsch E, Wimberger P, Classe JM, Gleeson N, von der Leyen H, Minsat M, Dubot C, Gestraud P, Kereszt A, Nagy I, Balint B, Berns E, Jordanova E, Saint-Jorre N, Savignoni A, Servant N, Hupe P, de Koning L, Fumoleau P, Rouzier R, Kamal M.

EBioMedicine. 2019 May;43:253-260. doi: 10.1016/j.ebiom.2019.03.069. Epub 2019 Apr 2.

22.

Rapid habituation of a touch-induced escape response in Zebrafish (Danio rerio) Larvae.

Roberts AC, Chornak J, Alzagatiti JB, Ly DT, Bill BR, Trinkeller J, Pearce KC, Choe RC, Campbell CS, Wong D, Deutsch E, Hernandez S, Glanzman DL.

PLoS One. 2019 Apr 4;14(4):e0214374. doi: 10.1371/journal.pone.0214374. eCollection 2019.

23.

The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features.

Limkin EJ, Reuzé S, Carré A, Sun R, Schernberg A, Alexis A, Deutsch E, Ferté C, Robert C.

Sci Rep. 2019 Mar 13;9(1):4329. doi: 10.1038/s41598-019-40437-5.

24.

Is breast-conserving therapy adequate in BRCA 1/2 mutation carriers? The radiation oncologist's point of view.

Vallard A, Magné N, Guy JB, Espenel S, Rancoule C, Diao P, Deutsch E, Rivera S, Chargari C.

Br J Radiol. 2019 May;92(1097):20170657. doi: 10.1259/bjr.20170657. Epub 2019 Feb 27. Review.

PMID:
30810334
25.

Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.

Annede P, Dumas I, Schernberg A, Tailleur A, Fumagalli I, Bockel S, Mignot F, Kissel M, Deutsch E, Haie-Meder C, Chargari C.

Brachytherapy. 2019 May - Jun;18(3):370-377. doi: 10.1016/j.brachy.2018.12.009. Epub 2019 Feb 21.

PMID:
30797698
26.

Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.

Bourgier C, Auperin A, Rivera S, Boisselier P, Petit B, Lang P, Lassau N, Taourel P, Tetreau R, Azria D, Bourhis J, Deutsch E, Vozenin MC.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):365-373. doi: 10.1016/j.ijrobp.2019.02.024. Epub 2019 Feb 15.

PMID:
30776452
27.

Using Simulation Technology to Improve Patient Safety in Airway Management by Practicing Otolaryngologists.

Sommerfeld C, Scott G, Fung K, Hp Nguyen L, Viallet N, Deutsch E, Gooi A.

Stud Health Technol Inform. 2019;257:393-398.

PMID:
30741229
28.

An IDEA: Safety Training to Improve Critical Thinking by Individuals and Teams.

Browne AM, Deutsch ES, Corwin K, Davis DH, Teets JM, Apkon M.

Am J Med Qual. 2019 Feb 9:1062860618820687. doi: 10.1177/1062860618820687. [Epub ahead of print]

PMID:
30739459
29.

CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance.

Mondini M, Loyher PL, Hamon P, Gerbé de Thoré M, Laviron M, Berthelot K, Clémenson C, Salomon BL, Combadière C, Deutsch E, Boissonnas A.

Cancer Immunol Res. 2019 Mar;7(3):376-387. doi: 10.1158/2326-6066.CIR-18-0633. Epub 2019 Jan 29.

PMID:
30696630
30.

Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy.

Bockel S, Escande A, Dumas I, Manea E, Morice P, Gouy S, Deutsch E, Haie-Meder C, Chargari C.

J Clin Med. 2019 Jan 21;8(1). pii: E125. doi: 10.3390/jcm8010125.

31.

Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer.

Loi M, Dunant A, Ghith S, Cascales-Garcia AM, Mazouni C, Pistilli B, Mathieu MC, Deutsch E, Arriagada R, Rivera S.

Cancer Invest. 2019;37(1):29-38. doi: 10.1080/07357907.2018.1564325. Epub 2019 Jan 18.

PMID:
30656969
32.

Hindcasting eutrophication and changes in temperature and storage volume in a semi-arid reservoir: a multi-decadal Landsat-based assessment.

Deutsch ES, Alameddine I.

Environ Monit Assess. 2018 Dec 28;191(1):41. doi: 10.1007/s10661-018-7180-7.

PMID:
30593606
33.

A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours.

de Weger VA, de Jonge M, Langenberg MHG, Schellens JHM, Lolkema M, Varga A, Demers B, Thomas K, Hsu K, Tuffal G, Goodstal S, Macé S, Deutsch E.

Br J Cancer. 2019 Feb;120(3):286-293. doi: 10.1038/s41416-018-0355-8. Epub 2018 Dec 26.

PMID:
30585255
34.

A Tandem Mass Spectrometry Sequence Database Search Method for Identification of O-Fucosylated Proteins by Mass Spectrometry.

Swearingen KE, Eng JK, Shteynberg D, Vigdorovich V, Springer TA, Mendoza L, Sather DN, Deutsch EW, Kappe SHI, Moritz RL.

J Proteome Res. 2019 Feb 1;18(2):652-663. doi: 10.1021/acs.jproteome.8b00638. Epub 2018 Dec 21.

PMID:
30523691
35.

Focus on the Number of Radiation Oncology Trials or on Clinical Relevance?

Chargari C, Massard C, Deutsch E.

JAMA Oncol. 2018 Dec 1;4(12):1791. doi: 10.1001/jamaoncol.2018.5116. No abstract available.

PMID:
30383141
36.

Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer.

Schernberg A, Mezquita L, Boros A, Botticella A, Caramella C, Besse B, Escande A, Planchard D, Le Péchoux C, Deutsch E.

PLoS One. 2018 Oct 10;13(10):e0204490. doi: 10.1371/journal.pone.0204490. eCollection 2018.

37.

Fate of manuscripts rejected by Intensive Care Medicine from 2013 to 2016: a follow-up analysis.

Citerio G, Deutsch E, Sala E, Lavillonnière M, Perner A, Jaber S, Timsit JF, Azoulay E.

Intensive Care Med. 2018 Dec;44(12):2300-2301. doi: 10.1007/s00134-018-5407-2. Epub 2018 Oct 8. No abstract available.

PMID:
30298204
38.

Macrophages in radiation injury: a new therapeutic target.

Meziani L, Deutsch E, Mondini M.

Oncoimmunology. 2018 Jul 23;7(10):e1494488. doi: 10.1080/2162402X.2018.1494488. eCollection 2018.

39.

Expanding the Use of Spectral Libraries in Proteomics.

Deutsch EW, Perez-Riverol Y, Chalkley RJ, Wilhelm M, Tate S, Sachsenberg T, Walzer M, Käll L, Delanghe B, Böcker S, Schymanski EL, Wilmes P, Dorfer V, Kuster B, Volders PJ, Jehmlich N, Vissers JPC, Wolan DW, Wang AY, Mendoza L, Shofstahl J, Dowsey AW, Griss J, Salek RM, Neumann S, Binz PA, Lam H, Vizcaíno JA, Bandeira N, Röst H.

J Proteome Res. 2018 Dec 7;17(12):4051-4060. doi: 10.1021/acs.jproteome.8b00485. Epub 2018 Oct 11.

40.

Simulation Saves the Day (and Patient).

Deutsch ES, Patterson MD.

Otolaryngol Clin North Am. 2019 Feb;52(1):115-121. doi: 10.1016/j.otc.2018.08.005. Epub 2018 Sep 22. Review.

PMID:
30249446
41.

Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients.

Loganadane G, Dhermain F, Louvel G, Kauv P, Deutsch E, Le Péchoux C, Levy A.

Front Oncol. 2018 Sep 5;8:336. doi: 10.3389/fonc.2018.00336. eCollection 2018. Review.

42.

Flexible and Fast Mapping of Peptides to a Proteome with ProteoMapper.

Mendoza L, Deutsch EW, Sun Z, Campbell DS, Shteynberg DD, Moritz RL.

J Proteome Res. 2018 Dec 7;17(12):4337-4344. doi: 10.1021/acs.jproteome.8b00544. Epub 2018 Sep 28.

43.

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

Lux F, Tran VL, Thomas E, Dufort S, Rossetti F, Martini M, Truillet C, Doussineau T, Bort G, Denat F, Boschetti F, Angelovski G, Detappe A, Crémillieux Y, Mignet N, Doan BT, Larrat B, Meriaux S, Barbier E, Roux S, Fries P, Müller A, Abadjian MC, Anderson C, Canet-Soulas E, Bouziotis P, Barberi-Heyob M, Frochot C, Verry C, Balosso J, Evans M, Sidi-Boumedine J, Janier M, Butterworth K, McMahon S, Prise K, Aloy MT, Ardail D, Rodriguez-Lafrasse C, Porcel E, Lacombe S, Berbeco R, Allouch A, Perfettini JL, Chargari C, Deutsch E, Le Duc G, Tillement O.

Br J Radiol. 2018 Sep 18:20180365. doi: 10.1259/bjr.20180365. [Epub ahead of print]

PMID:
30226413
44.

Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applications.

Bockel S, Durand B, Deutsch E.

Cancer Radiother. 2018 Oct;22(6-7):567-580. doi: 10.1016/j.canrad.2018.07.136. Epub 2018 Sep 6. Review.

PMID:
30197026
45.

Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy.

Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Radiother Oncol. 2019 Jan;130:89-96. doi: 10.1016/j.radonc.2018.08.013. Epub 2018 Aug 29.

PMID:
30172455
46.

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C.

Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14.

PMID:
30120041
47.

Progress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome Project.

Omenn GS, Lane L, Overall CM, Corrales FJ, Schwenk JM, Paik YK, Van Eyk JE, Liu S, Snyder M, Baker MS, Deutsch EW.

J Proteome Res. 2018 Dec 7;17(12):4031-4041. doi: 10.1021/acs.jproteome.8b00441. Epub 2018 Aug 23.

48.

A tissue-based draft map of the murine MHC class I immunopeptidome.

Schuster H, Shao W, Weiss T, Pedrioli PGA, Roth P, Weller M, Campbell DS, Deutsch EW, Moritz RL, Planz O, Rammensee HG, Aebersold R, Caron E.

Sci Data. 2018 Aug 7;5:180157. doi: 10.1038/sdata.2018.157.

49.

[Editorial].

Deutsch E; Le groupe TEP-RT.

Cancer Radiother. 2018 Sep;22(5):383. doi: 10.1016/j.canrad.2018.07.009. Epub 2018 Aug 3. French. No abstract available.

PMID:
30082201
50.

[Radiation therapy planning for Hodgkin lymphoma: Focus on intensity-modulated radiotherapy, gating, protons. Which techniques to best deliver radiation?]

Boros A, Ribrag V, Deutsch É, Chargari C, Izar F.

Cancer Radiother. 2018 Sep;22(5):404-410. doi: 10.1016/j.canrad.2018.07.007. Epub 2018 Jul 31. Review. French.

PMID:
30076071

Supplemental Content

Loading ...
Support Center